Imaging and 2-year clinical outcomes of thin strut sirolimus-eluting bioresorbable vascular scaffold: The MeRes-1 extend trial.
Alexandre AbizaidSasko KedevRosli Bin Mohd AliTeguh SantosoAngel CequierRobert-Jan Van Geuns van GeunsBernard ChevalierFarrel HelligRicardo CostaYoshinobu OnumaJose Ribamar CostaPatrick W J C SerruysSubhash BanerjeePublished in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2020)
The clinical and imaging outcomes of MeRes-1 Extend trial demonstrated favorable safety and efficacy of MeRes100 sirolimus-eluting BRS in patients with de novo coronary artery lesions.